{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T17:02:44Z","timestamp":1785862964706,"version":"3.56.0"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1097\/01.mph.0000212986.41564.e9","type":"journal-article","created":{"date-parts":[[2006,9,26]],"date-time":"2006-09-26T04:21:30Z","timestamp":1159244490000},"page":"627-629","source":"Crossref","is-referenced-by-count":6,"title":["Failure of Viridans Group Streptococci Causing Bacteremia in Pediatric Oncology Patients to Express Superantigens"],"prefix":"10.1097","volume":"28","author":[{"given":"Esobe F.","family":"Ohuoba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita G.","family":"Kansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall T.","family":"Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"Kotb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth E.","family":"Adderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20210227","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S1473-3099(02)00222-0","article-title":"Superantigens: microbial agents that corrupt immunity","volume":"2","author":"Llewelyn","year":"2002","journal-title":"Lancet Inf Dis"},{"key":"R2-15-20210227","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1001\/jama.1993.03500030088038","article-title":"Defining the group A streptococcal toxic shock syndrome: rationale and consensus definition","volume":"269","year":"1993","journal-title":"JAMA"},{"key":"R3-15-20210227","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0924-8579(99)00172-7","article-title":"Viridans-group streptococcal infections in immunocompromised hosts","volume":"14","author":"Shenep","year":"2000","journal-title":"Int J Antimicrob Agents"},{"key":"R4-15-20210227","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1128\/JCM.41.7.3051-3055.2003","article-title":"Major outbreak of toxic shock-like syndrome caused by Streptococcus mitis","volume":"41","author":"Lu","year":"2003","journal-title":"J Clin Microbiol"},{"key":"R6-15-20210227","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1128\/CMR.15.4.613-630.2002","article-title":"What happened to the streptococci: overview of taxonomic and nomenclature changes","volume":"15","author":"Facklam","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"R7-15-20210227","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1128\/IAI.68.6.3523-3534.2000","article-title":"Genetic relatedness and superantigen expression in group A Streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases","volume":"68","author":"Chatellier","year":"2000","journal-title":"Infect Immun"},{"key":"R8-15-20210227","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/314872","article-title":"Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome","volume":"180","author":"Eriksson","year":"1999","journal-title":"J Inf Dis"},{"key":"R9-15-20210227","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1080\/00365540310015944","article-title":"Intravenous immunoglobulin adjunctive therapy in sepsis, with special emphasis on severe invasive Group A streptococcal infections","volume":"35","author":"Norrby-Teglund","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"R10-15-20210227","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0887-7963(03)00038-5","article-title":"Risks associated with the use of intravenous immunoglobulin","volume":"17","author":"Pierce","year":"2003","journal-title":"Trans Med Rev"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.mph.0000212986.41564.e9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:01:42Z","timestamp":1785859302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200609000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.mph.0000212986.41564.e9","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}